Tag: Kidney Problems: Misc.
Canagliflozin Beneficial Even for Advanced Kidney Disease
Canagliflozin slows progression of kidney disease in participants with eGFR <30 mL/min/1.73 m2 with no increase in AKI
CVD Risk Higher in T2DM Even With Optimal Risk Factor Management
Those with T2DM with optimal risk factor control have greater risk for cardiovascular disease events versus those without T2DM
AHA: Sotagliflozin Beneficial for T2DM With Heart Failure
Second study shows benefits among patients with type 2 diabetes and chronic kidney disease, risks for CVD
Contraceptive Use Low Among Women With Kidney Disease
Overall rate of contraceptive use 5.3 percent of person-years
U.S. Nephrology Trainees Doubt Skill in Home Hemodialysis
Most respondents report being moderately confident about principles of peritoneal dialysis, but few had initiated urgent-start PD
Guidelines Developed for Diabetes Management in CKD
Recommendations and practice points relate to comprehensive care needs, glycemic monitoring, lifestyle interventions
AKI Common in U.S. Veterans Hospitalized With COVID-19
AKI associated with increased odds of mechanical ventilation use, longer hospital stay, increased risk for death
New Equation Estimates GFR Across Age Spectrum
But EKFC equation was developed and validated only in White populations
ASN: Finerenone May Slow Progression in CKD With T2DM
